For years we’ve been claiming that while HbA1C may be the gold standard for measuring outcomes, it’s an incomplete measurement. Yes, it’s true that HbA1C is the easiest number for a patient to understand, anything below 7 is considered good control, this biomarker fails to consider other factors such as glycemic variability. Thanks to CGM we now know that time in range is just as important as HbA1C and it seems finally the diabetes world is coming around to this same view.
According to an article in the recent issue of Diabetes Care;
“The Steering Committee recommends . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.